v3.26.1
Nature of the Business and Presentation (Details)
 3 Months Ended 12 Months Ended
Mar. 18, 2026
USD ($)
Oct. 22, 2025
$ / shares
shares
Mar. 24, 2025
USD ($)
$ / shares
shares
Mar. 21, 2025
USD ($)
$ / shares
shares
Mar. 31, 2026
USD ($)
$ / shares
shares
Mar. 31, 2025
USD ($)
Dec. 31, 2025
USD ($)
Sep. 27, 2023
USD ($)
Nature of the Business [Line Items]                
Contract value               $ 150,000,000
Initial award amount               54,900,000
Contract additional value         $ 63,400,000      
Contract description         (i) a no-cost extension of the base phase of the contract from March, 2026 to June 2026 and (ii) accelerated funding of approximately $31.7 million for further follow-on development and procurement activities related to the DeepView System      
Development costs $ 9,700,000       $ 9,700,000      
Number of operating segments         1      
Provision for income tax         $ (10,000) $ 71,000    
Effective tax rate         (0.30%) 2.40%    
Allowance for credit loss            
Cash         11,700,000   15,400,000  
Accumulated deficit         (59,212,000)   (55,800,000)  
Notes payable         8,400,000   8,400,000  
Long-term debt         4,500,000   $ 5,500,000  
Other Borrowings     $ 15,000,000          
Long-term debt, initial draw-down value     $ 8,500,000          
Aggregate shares (in Shares) | shares       2,076,923        
Offering price (in Dollars per share) | $ / shares       $ 1.3        
Additional amount       $ 2,700,000        
Share issued         $ 3,080,000    
Aggregate gross proceeds         $ 7,600,000      
Warrants issuance date         5 years      
Ongoing partnership 86,600,000              
Contract with an overall value 150,000,000              
Public Warrants [Member]                
Nature of the Business [Line Items]                
Number of warrants issued (in Shares) | shares     8.5          
Consecutive trading days     5 days          
Lowest price per share (in Dollars per share) | $ / shares     $ 1.66          
Warrant [Member]                
Nature of the Business [Line Items]                
Warrants exercise price per share (in Dollars per share) | $ / shares         $ 2.51      
Common Stock [Member]                
Nature of the Business [Line Items]                
Shares of common stock (in Shares) | shares   3,065,000   2,068,846 4,000,000      
Price per share of offering (in Dollars per share) | $ / shares   $ 1.9   $ 1.3        
Share issued         $ 900,000      
Customer Concentration Risk [Member] | Customer One [Member] | Accounts Receivable [Member]                
Nature of the Business [Line Items]                
Concentration risk, percentage         100.00%   100.00%  
Customer Concentration Risk [Member] | Customer One [Member] | Revenue Benchmark [Member]                
Nature of the Business [Line Items]                
Concentration risk, percentage         83.00% 95.00%    
Texas Franchise Tax [Member]                
Nature of the Business [Line Items]                
Provision for income tax         $ 10,000 $ 71,000    
Food and Drug Administration [Member]                
Nature of the Business [Line Items]                
Contract additional value               $ 95,000,000
Common Stock [Member]                
Nature of the Business [Line Items]                
Advancement of contract $ 31,700,000